References
- La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113–30
- Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 2012;10:32
- Krasnoploskaya KV, Nazarenko TA. Clinical aspects of treatment of infertility in married women. Мoscow: Geotar-Media; 2013:376
- Kaushal S. Ovarian hyperstimulation syndrome. Blood Pressure 2011;90:60
- Pratap K, Sameer FS, Alok S, Mukesh K. Ovarian hyperstimulation syndrome. J Hum Reprod Sci 2011;4:70–5
- Misso ML, Costello MF, Garrubba M, Wong J. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2013;19:2–11
- Insler V, Lunenfeld B. Pathogenesis of ovarian hyperstimulation syndrome. Available from: http://www.uptodate.com/contents/pathogenesis-of-ovarian-hyperstimulation-syndrome [last accessed 10 Jun 2014]
- Delvigne A, Rozenberg S. Ovarian hyperstimulation syndrome (OHSS) guidelines. J Hum Reprod 2001;16:2491–5
- Delvigne A. Symposium: update on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online 2009;19:8–13
- Panicker V, Wilson SG, Spector TD, et al. Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort. Clin Endocrinol 2008;68:652–9
- Jourdan C, Linseisen J, Meisinger C, Petersen AK. Associations between thyroid hormones and serum metabolite profiles in an euthyroid population. Metabolomics 2014;10:152–64
- Hedayati OM, Molaei Langroudi R, Ghazanfari Amlashi F, Sadri S. Ovarian hyperstimulation syndrome and autoimmune primary hypothyroidism in two members of a family. J Clin Case Rep 2012;2:113